• 1. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 2. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 3. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 4. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330
• 5. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932

2-(4-Bromo-1H-Pyrazol-1-yl)-1-(1-Piperazinyl)Ethanone: A Comprehensive Overview

The compound with CAS No. 1006348-89-5, known as 2-(4-bromo-1H-pyrazol-1-yl)-1-(1-piperazinyl)ethanone, is a structurally complex organic molecule that has garnered significant attention in the fields of medicinal chemistry and pharmacology. This compound is notable for its unique combination of functional groups, including a pyrazole ring, a piperazine moiety, and a ketone group. These structural elements contribute to its potential biological activity and make it a subject of interest for researchers exploring novel therapeutic agents.

Pyrazole, a five-membered aromatic heterocycle containing two nitrogen atoms, is a common structural motif in many bioactive compounds. In this molecule, the pyrazole ring is substituted with a bromine atom at the 4-position, which may influence its electronic properties and reactivity. The piperazine group, a six-membered ring containing two nitrogen atoms, is known for its ability to form hydrogen bonds and interact with biological targets such as enzymes or receptors. The combination of these groups with the ketone moiety creates a versatile scaffold that can be further modified to enhance specific pharmacological properties.

Recent studies have highlighted the potential of 2-(4-bromo-1H-pyrazol-1-yl)-1-(1-piperazinyl)ethanone as a lead compound in drug discovery. For instance, research has demonstrated its ability to inhibit certain kinases, which are key players in various pathological processes such as inflammation and cancer. The bromine substitution at the pyrazole ring has been shown to enhance the compound's selectivity and potency against specific targets, making it a promising candidate for further optimization.

The synthesis of this compound involves a multi-step process that typically begins with the preparation of the pyrazole derivative. Advanced synthetic techniques, such as Suzuki coupling or Buchwald-Hartwig amination, are often employed to construct the piperazine moiety. Researchers have also explored various strategies to improve the yield and purity of the final product, including optimization of reaction conditions and purification methods.

In terms of biological activity, 2-(4-bromo-1H-pyrazol-1-yl)-1-(1-piperazinyl)ethanone has been investigated for its potential anti-inflammatory, antitumor, and antimicrobial properties. Preclinical studies have shown that it exhibits significant activity against inflammatory cytokines such as TNF-alpha and IL-6, suggesting its potential use in treating inflammatory diseases. Additionally, its ability to induce apoptosis in cancer cells has been reported in several studies, highlighting its role as a potential anticancer agent.

The pharmacokinetic properties of this compound are also under active investigation. Studies have shown that it demonstrates moderate solubility in aqueous solutions and good permeability across biological membranes. These characteristics are favorable for oral administration, although further research is needed to optimize its bioavailability and half-life.

From an environmental perspective, 2-(4-bromo-1H-pyrazol-1-yl)-1-(1-piperazinyl)ethanone has been evaluated for its biodegradability and ecotoxicity. Initial findings suggest that it undergoes rapid degradation under aerobic conditions, minimizing its environmental footprint. However, additional studies are required to fully understand its impact on aquatic ecosystems.

In conclusion, 2-(4-bromo-1H-pyrazol-1-yl)-1-(1-piperazinyl)ethanone (CAS No. 1006348-89-5) represents a valuable addition to the arsenal of bioactive compounds being explored for therapeutic applications. Its unique structure, combined with promising biological activity and favorable pharmacokinetic properties, positions it as a compelling candidate for further development in drug discovery efforts.

• 88106-61-0(1H-Pyrazole-1-ethanamine, N-[2-(1H-pyrazol-1-yl)ethyl]-)
• 381721-56-8(1-2-(1H-pyrazol-1-yl)ethylpiperazine)
• 16034-48-3(2-(1H-Pyrazol-1-Yl)Acetic Acid)
• 1152853-30-9(2-(4-Amino-1H-pyrazol-1-yl)-N-methylacetamide Dihydrochloride)
• 302542-57-0(1H-Pyrazole-1-acetamide,N-(4-methylphenyl)-)
• 71033-38-0(1-(N,N-DiethylaMinoethyl)pyrazole)
• 1187385-66-5((1-2-Piperidinoethyl)pyrazole)
• 302542-49-0(1H-Pyrazole-1-acetamide,N-(3-methylphenyl)-)
• 302542-40-1(1H-Pyrazole-1-acetamide,N-(2-methylphenyl)-)
• 1111096-05-9(4-[2-(1H-pyrazol-1-yl)ethyl]morpholine)